NASHVILLE, Tenn., April 24, 2018 -- Aegis Sciences Corporation, a leading healthcare sciences and forensic toxicology laboratory, is pleased to announce that Dr. Elaine Jeter has joined the company as its Senior Medical Policy Advisor.
“I am delighted to welcome Dr. Elaine Jeter,” said Dr. Frank Basile, Aegis’s Chief Executive Officer. “Dr. Jeter’s wealth of experience in clinical medicine and Medicare will be very valuable to Aegis.”
As Senior Medical Policy Advisor, Dr. Jeter will assist with both regulatory and medical coverage policy engagement and compliance, new and existing Managed Care relationships, and development of appropriate evidence-based clinical utility evidence for Aegis’s new and innovative testing services.
In regards to her decision to serve as Aegis’s Senior Medical Policy Advisor, Dr. Jeter said, “I am excited to join the Aegis team in this critical role as it has and continues to maintain a pristine track record for quality, compliance and integrity in toxicology testing, which is manifest at all levels within the organization.”
Prior to joining Aegis, Dr. Jeter was the Senior Medical Director at Palmetto GBA, a Medicare Administrative Contractor that administers Medicare health insurance for the Centers for Medicare & Medicaid Services (CMS) throughout the U.S. At Palmetto GBA, Dr. Jeter developed and directed the MolDX program, which was created to uniquely identify laboratory tests, primarily sole-source and molecular tests, and to determine the clinical value of a test by way of a technical assessment. The assessments were subsequently developed into Medicare local coverage decision policies. In the field of toxicology, her “Controlled Substance Monitoring and Drugs of Abuse Testing” coverage policy has largely become the model across the country for providers and payers alike.
Dr. Jeter has practiced surgical pathology and directed clinical laboratories in academia and the private practice. She completed her medical school and residency training at the Medical University of South Carolina (MUSC) in Charleston, SC. She is board certified in Anatomic and Clinical Pathology, with sub-specialty boards in Blood Banking and Transfusion Medicine.
About Aegis Sciences Corporation
Founded in 1990, Aegis Sciences Corporation is a laboratory sciences company based in Nashville, TN, that provides science-driven testing and consulting services for clients such as healthcare providers, pharmaceutical companies, professional and amateur sports organizations, leading college and university athletic programs, Fortune 500 corporations, and government agencies throughout the United States. For more information please visit http://www.aegislabs.com/
Contact:
Stephanie Protz, Manager, Marketing Communications
[email protected]
615-577-4535


Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Washington Post Publisher Will Lewis Steps Down After Layoffs
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 



